“…In recent years, retinal thinning has become heavily associated with neurodegenerative diseases of the brain (Helmer et al, 2013;Sivak, 2013). There have been correlations established between retinal thinning and Alzheimer's disease (Chiquita et al, 2019;Cipollini et al, 2019;den Haan et al, 2019), Parkinson's disease (Ahn et al, 2018;Satue et al, 2018), Huntington's disease (Dhalla et al, 2019), Amyotrophic lateral sclerosis (Hubers et al, 2016;Mukherjee et al, 2017), and a case has been reported of reduced retinal thickness after an occipital lobe infarction (Tanito and Ohira, 2013). Given this, it is important that we consider exploring biomarkers of the retina as possible routes of monitoring and diagnosing these debilitating neurodegenerative diseases.…”